UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	January 6, 2022 4:00 P.M.

Form:	S-1
CIK: 0001658551 Company Name: Amylyx Pharmaceuticals, Inc. File Number: 333-261703